The US Department of Health and Human Services (HHS) failed to notify state officials on Friday that it plans to end the COVID-19 emergency, signaling that the Biden administration will upheld the statement that January passed.
The emergency designation, first issued in January 2020 when the pandemic began to counter its impact on public health, has been renewed quarterly for 90 days.
HHS is committed to notifying states 60 days before the emergency expires, i.e. by Friday, if the declaration was last extended in October ending January 11.
Without such announcement by Friday, the COVID-19 public health emergency could extend into the spring, The The Wall Street Journal report.
The federal designation has allowed millions of Americans to be tested, vaccinated, and treated for free.
The move has also led to a dramatic expansion of public health coverage offered through Medicaid and the Children’s Health Insurance Program.
In October, HHS Secretary Xavier Becerra said that how the United States responds to COVID-19 this fall and winter will help determine whether to extend the emergency declaration.
However, the Biden administration began signaling in August that the state of emergency would likely end in January as plans were underway to transform government-led COVID-19 vaccine procurement practices. directing and therapy for the commercial market.
COVID-19 treatment developer: Pfizer (PFE), Merck (A), Eli Lilly (LLY)/AbCellera (ABCL) Gilead (GILD), Eli Lilly (LLY), Vir Biotechnology (HOROSCOPE)/ GlaxoSmithKline (GSK), Regeneron (REGISTER)/Roche (OTCQX:RHHBF)
Dear Reader: We realize that politics often intertwine with the financial news of the day, so we invite you to click here for engage in separate political discussions.